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Abstract
Purpose The use of alloplastic meshes for repair of
female pelvic organ prolapse (POP) has recently been
discussed for its indications and safety. Mesh exposure and
chronic pelvic pain are among the risks that need to be
addressed to the patients. The purpose of this prospective
observational study is to investigate the effect of vaginal
mesh implantation on pelvic floor-related quality of life
(QoL).
Methods 55 patients were included in this prospective
multicenter study. A validated QoL questionnaire com-
prising items on prolapse symptoms and bladder, bowel
and sexual function was used. QoL data were acquired
before and 1 year after POP surgery. Patients underwent
POP surgery with implantation of either Prolift or Ser-
atom mesh.
Results Quality of life scores improved significantly after
surgery. Prolapse complaints were reduced from 4.43 to
0.26 (p \ 0.001), and bladder and bowel complaints
improved from 3.03 to 1.46 (p \ 0.001) and from 1.93 to
1.60 (p \ 0.01) at follow-up. Furthermore, the sexual
function score improved from 2.31 to 1.12 postoperatively
(p \ 0.01).
Conclusion Despite the risks discussed for vaginal mesh
repair, we observed a statistically significant improvement
of pelvic floor-related quality of life of POP patients.
Keywords Pelvic organ prolapse  Polypropylene
mesh  Quality of life  Sexuality
Introduction
The incidence of pelvic organ prolapse (POP) among
women is high [1]. Up to 60 % of women suffer from
different forms of genital prolapse, mainly due to preg-
nancy and vaginal delivery [2]. Another predisposing fac-
tor is continuous intra-abdominal pressure, for example due
to chronic bronchitis or obesity [3–6]. The resulting com-
plaints are versatile and often accompanied by urinary
incontinence representing a huge burden for women. Uri-
nary tract dysfunction, urge symptoms and recurrent uri-
nary tract infection can arise as a result of POP [7]. The
implications on patients’ quality of life and sexuality can
be far-reaching. Women may refrain from sexual activity
due to prolapse symptoms. However, many women do not
seek help from their physicians as they feel ashamed [8].
Previous studies showed recurrence rates of up to 40 %
after native tissue repair of POP [9–11]. POP surgery has
experienced a fundamental change by the establishment of
vaginal meshes. Meshes have been widely used; however,
few studies are currently available regarding long-term
results. Some studies showed improved QoL scores after
mesh implantation [10]. An often raised criticism about
vaginal mesh implantation is the risk of dyspareunia and
chronic pelvic pain. Another topic of discussion is whether
SUI treatment should be conducted simultaneously or after
POP surgery. The prevalence of de novo SUI after POP
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surgery was reported between 0 and 12 % in different
studies [12–15].
Most of the previous studies defined success of POP
surgery as postoperative reconstruction of the defect and
improvements in general symptoms. Subjective recovery
and sexuality were investigated as the secondary subjects
in these studies. In our study, the patients’ pelvic floor-
related quality of life was assessed pre- and
postoperatively.
The overall aim of this prospective, multicenter study
was to evaluate the implications of vaginal mesh implan-
tation on patients’ quality of life and sexuality 1 year after
the operation.
Materials and methods
The study was conducted between 2007 and 2009. 60
patients undergoing surgery for POP either at the Depart-
ment of Obstetrics and Gynecology at the University
Medical Center Freiburg or the Department of Obstetrics
and Gynecology at the Hospital of Waldshut in Germany
were prospectively recruited for the study. All patients had
symptomatic anterior and/or apical prolapse C2 (see
Table 1). The indication for the use of mesh was based on
the surgeon’s decision, either due to previous surgery,
considerable lateral defect or risk factors for recurrent
prolapse (obesity, chronic obstructive pulmonary disease,
etc.). The choice of the type of mesh used was made by the
surgeon. The meshes were those commonly used at the
participating hospitals. The ethical approvals were obtained
from ethical committees of the University of Freiburg and
Medical Association for the State of Baden-Wu¨rttemberg.
Surgery
Preoperative estrogen treatment was administered to post-
menopausal patients. Single-shot antibiotic therapy was
given. Both implants used (Prolift, Gynecare Johnson &
Johnson, Baltimore, USA and Seratom, Serag Wiessner
KG, Naila, Germany) are made from macroporous, mono-
filament polypropylene. The anterior meshes had four arms
for the transobturator approach; in case of the total mesh
(Prolift) and of the posterior mesh, fixation was through
the sacrospinous ligament. After colpotomy and dissection
of the endopelvic fascia, the meshes were implanted using
the devices provided by the manufacturers. Excessive tis-
sue of the vaginal wall was not resected to prevent mesh
exposure. After implantation of the mesh, the vaginal wall
was closed using a running suture.
Quality of life questionnaire and evaluation of sexual
function
All patients scheduled for mesh implantation in one of the
two hospitals were asked to participate in the study.
Informed consent was obtained from all women. QoL data
were acquired before and 1 year after surgery. Patients
filled out the ‘‘German pelvic floor questionnaire’’ [16],
covering items on prolapse symptoms and bladder, bowel
and sexual function.
Statistical analysis
The statistical software SPSS Version 17.0 was used to
analyse the data. Frequency analysis was computed to get
descriptive information. Median, standard deviation, min-
imum and maximum values were calculated for each case.
The pre- and postoperative scores of each function were
compared. In addition pre- and postoperative total scores
were calculated and compared. Paired t test was used to test
the difference between preoperative and postoperative
scores.
Results
Localization of prolapse and surgery
Table 1 depicts the distribution of the POP stages in the
study population. Apart from mesh implantation, the fol-
lowing additional procedures were performed: anterior
colporrhaphy (36 patients), combined anterior and poster-
ior colporrhaphy (18 patients) and one posterior colpor-
rhaphy with mesh insertion. Table 2 displays the types of
mesh used.
Table 1 Preoperative prolapse compartment (n = 55)
Prolapse stage Anterior Combined Posterior
n % n % n %
Stage I 1 1.8 1 1.8 0 0
Stage II 10 18 1 1.8 0 0
Stage III 25 45.5 13 23.6 1 1.8
Stage IV 0 0 3 5.5 0 0
Table 2 Type of mesh used
Anterior Combined Posterior
n % n % n %
Gynecare Gynemesh PS Prolift 9 16 10 18 1 1.8
Seratom 27 49 8 14 0 0
818 Arch Gynecol Obstet (2014) 289:817–821
123
Patients’ demographics
Of the 60 patients included in the study, 55 could be
taken for analysis. Median follow-up time was
12.4 months. The response rate was 91 %: two patients
were excluded from the study as they filled out the
questionnaire only after surgery. Three more did not fill
out the questionnaire after 1 year. The median age was
64.3 years (min = 44, max = 81 years). The mean num-
ber of vaginal deliveries was 2.46. Of the patients 2 (3 %)
were nulliparous, 7 (13 %) had one vaginal birth, 44
(80 %) 2–4 vaginal births and 2 (4 %) experienced more
than five births.
Sexual activity
Of the 55 patients, 13 (24 %) were regularly and 17
(31 %) seldom sexually active before the operation. 25
women (45 %) were not sexually active preoperatively.
The reasons for being not sexually active were as fol-
lows: 8 (31 %) patients did not have a partner, 7 (27 %)
had an impotent partner, 2 (8 %) were not interested in
sexual intercourse, 1 (4 %) had impaired lubrication, 6
(11 %) were embarrassed due to incontinence or pro-
lapse, 1 (4 %) felt ‘very’ old, 1 (4 %) due to other
reasons. Sexual activity rates and the reasons for inac-
tivity before and after the treatment are depicted in
Tables 3 and 4.
Dyspareunia
Frequency of dyspareunia was also explored by the state-
ments of patients on a four point scale (never, seldom,
mostly and always). Localization of dyspareunia (n = 12)
preoperatively was explored with further questions. Five
patients (42 %) felt pain during sexual intercourse at the
introitus of the vagina, three patients (25 %) deep inside
the pelvis, three patients (25 %) at the introitus and deep
inside, and one patient (8 %) made no statement about the
localization.
Localization of dyspareunia (n = 10) postoperatively
was stated as follows: two (20 %) felt pain during sexual
intercourse at the introitus, five patients (50 %) deep inside
the pelvis, two patients (20 %) at the introitus of the vagina
and deep inside, and one patient (10 %) made no statement
about the localization. Three (11 %) patients reported de
novo dyspareunia. The difference of the pre- and postop-
erative values did not show statistical significance.
Incontinence and bladder function
54 patients could be evaluated regarding urinary inconti-
nence. The effect of incontinence on QoL was explored by
a four point scale. 36 patients (67 %) complained about
urge incontinence before surgery. While 22 patients (41 %)
still expressed suffering, 14 (26 %) stated improvement
1 year after the operation, however, this was not statisti-
cally significant. 30 patients (54 %) expressed complaints
about stress urinary incontinence (SUI) before the opera-
tion, which was improved in 19 (35 %) postoperatively
(n.s.). Four (7 %) patients showed de novo urge inconti-
nence and 7 (12 %) de novo SUI.
Bladder function complaints were explored by different
statements about ‘slow stream of urine’, ‘not completely
emptied bladder’ or need to ‘press to urinate’. Apart from
the improvement of incontinence problems, bladder func-
tion was also positively changed after 1 year: the differ-
ences between pre- and postoperative statements,
‘incomplete emptying of bladder’ (p \ 0.001); ‘press to
urinate’ (p \ 0.05) and ‘slow stream of urine’ (p \ 0.001),
were statistically significant. For details see Tables 5 and 6.
Table 3 Sexual activity
Preoperative Postoperative
n % n %
Not active 25 45.5 25 45.5
Seldom 17 30.9 17 30.9
Regularly 13 23.6 11 20.0





No partner 8 8
Partner unable 7 7
Not interesting in sexuality 2 4
Vaginal dryness 1 –





Not specified – 5
Table 5 Bladder function
Preoperative Postoperative p
n1 n2 n1 n2
Incomplete emptying of
bladder
14 38 34 21 \0.001
Need to press to urinate 32 23 46 8 \0.05
Slow stream of urine 9 44 27 24 \0.001
n1 ‘never’; n2 ‘sometimes’, ‘often’, ‘always’
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Quality of life scores
In all four aspects of the questionnaire we could observe
statistically significant improvement of quality of life
scores 1 year after surgery. The mean preoperative bladder
function score improved from 3.03 to 1.46 after the surgery
(p \ 0.001), prolapse score 4.43 (SD = 1.96) to 0.26
(SD = 0.62) postoperatively. Bowel function score chan-
ged from 1.93 to 1.60 postoperatively (p \ 0.01). Fur-
thermore, also sexual function score showed an
improvement from 2.31 to 1.12 (p \ 0.01). Table 7 shows
the pre- and postoperative QoL scores.
Discussion
We present a prospective multicenter study on the effects
of vaginal mesh implantation on patients’ quality of life
and sexuality. Special attention was paid to the changes in
bladder function after the operation. Some of the findings
regarding the comparison between pre- and postoperative
values are not statistically significant, however, a positive
trend could be observed.
The relationship between POP and sexual function is dis-
cussed controversially, some studies describe a close rela-
tionship [17], whereas others do not see this correlation [18,
19]. Patients undergoing POP surgery are often postmeno-
pausal, but this does not mean that sexual function can be left
out of sight when counseling women on POP repair [20].
Apart from problems related to POP itself, pelvic floor
repair, no matter whether with native tissue or alloplastic
mesh, may result in dyspareunia [21]. About half of our
study population was not sexually active, in most cases due
to partner problems (no partner/partner sick or impotent).
Pain was only seldom named as reason for inactivity. In our
population, we observed a statistically significant
improvement of sexual function score; however, the per-
centage of patients sexually active before and after the
operation was almost similar. Nearly a quarter of the
patients stated feeling ashamed due to POP as the reason
for not being sexually active. Of those, 12 % were sexually
active 1 year after the operation, which may be due to an
improved body image. This finding shows that the
improvement is in the qualitative aspect rather than the
numbers of the sexually active women.
Furthermore, an improvement of dyspareunia was
observed in 17.8 % of our patients, with a rate of de novo
dyspareunia of 10.7 %. To better evaluate pelvic floor pain
and not only dyspareunia, a visual analog scale could be
useful for further studies.
25.9 and 20 % of the patients stated improvements of
urge or stress incontinence complaints. This of course is
only a subjective assessment, as it was not confirmed by
urodynamic testing. Improvement of incontinence com-
plaints can be explained by stress-free suspension of the
urethra by mesh implantation. The 12 % rate of de novo
SUI is in accordance with other recent studies [12, 22].
This again strengthens that a mid-urethral sling should
rather be implanted in a second operation to avoid unnec-
essary treatment. Otherwise, too many patients would
receive a sling without needing it. Also the rate of de novo
urge incontinence is in accordance with other studies.
In our study, pelvic floor-related QoL scores were sig-
nificantly improved 1 year after the operation. Similar
improvements in the QoL scores were observed in other
studies [10].
Summing up, we could observe positive effects of
vaginal mesh implantation on patients’ quality of life
1 year after surgery. Sexual function of our patients was
not impaired after surgery. These results point out that,
apart from better anatomical results of vaginal mesh
implantation compared to native tissue repair the subjective
outcome is satisfying. However, it should be tested in
randomized studies whether there is a difference in QoL
outcome between the two techniques. As vaginal mesh
implantation might have serious complications, the opera-
tion should not be performed uncritically. It should only be
carried out after thoroughly counseling the patients and
explaining possible alternatives.
Table 6 Psychological strain–
bladder function complaints
n1 ‘‘not at all’’; n2 ‘‘slightly’’,
‘‘moderately’’; n3 ‘‘extremely’’
n1 n2 n3





9 16 10 18 1 1.8
Table 7 Quality of life score pre- and postoperatively (n = 55)
Preoperative Postoperative p
Prolapse score 4.43 0.26 \0.001
Bladder function score 3.03 1.46 \0.001
Bowel function score 1.93 1.60 \0.01
Sexual function score 2.31 1.12 \0.01
Total score 0.26 0.05 \0.001
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